Articles Related to herbs

The fruit of Crataegus dahurica Koehne ex C.K. Schneid is an edible wild fruit and herb for the treatment of various diseases. However, few studies were conducted to search the chemical constituents of the edible herb. In the present study, a new glycoglycerolipid (1), together with ten known compounds, 2-oxo pomolic acid (2), cecropiacic acid (3), nikoenoside (4), garcimangosone D (5), ampelopsisionoside (6), saussureosides B (7), 6-O-[(2E, 6S)-2, 6-dimethyl-6-hydroxy-2, 7-octadienoyl]-α-D-glucopyranoside (8), 6-O-[(2E, 6S)-2, 6-dimethyl6-hydroxy-2, 7-octadienoyl]-β-D-glucopyranoside (9), betulalbuside A (10), quercetin (11), were isolated from the fruits of C. dahurica with various chromatographic techniques.

View complete article: PDF  |  Full-text

The concept of an effective cognitive boosting nootropic supplement is gaining traction with consumers, neuroscientists and regulators alike and it is therefore unsurprising that scientifically validated Nootropics are highly prized. New research demonstrates edible crops could be useful sources to mine for new nootropics; plant extracts enriched with an array of cognitive enhancing metabolites. There is merit in investigating these plant species. Metadata has identifies consuming specific fruit and vegetables positively affects cognitive function; therefore these same edible crop plants present as opportunities for developing nootropic formulations. This hypothesis is supported by positive data obtained through clinical testing [e.g. extracts of tomato (Solanum lycopersicum), herbs from the Genus Salvia, cocoa (Theobroma), tea (Camellia sinensisor) and coffee (Coffea Arabica). This review will discuss clinically tested cognitive enhancers derived from edible crop species and discuss their use alongside other classes of nootropics.

View complete article: PDF  |  Full-text

Like a drug for a purpose of treating or preventing a disease, a health food has to be scientifically evaluation and officially approved before it legally is marketed in China.

View complete article: PDF  |  Full-text

The objective of this investigation was to evaluate the efficacy and safety of purified Shilajit in moderately arthritic dogs. Ten client-owned dogs in a randomized double-blinded study received either a placebo or Shilajit (500 mg) twice daily for a period of five months. Dogs were evaluated each month for physical condition (body weight, body temperature, heart rate, and respiration rate) and pain associated with arthritis (overall pain, pain from limb manipulation, and pain after physical exertion).

View complete article: PDF  |  Full-text  | Digital